DuPont — Nov 6, 2025 release

• Operating EBITDA margin of 31.6% decreased 140 basis points primarily due to unfavorable mix and headwinds from currency. 3 Financial Outlook Dollars in millions, unless noted Current Guidance Full Year 2025* Prior Guidance Full Year 2025* Current Guidance 4Q’25* Net sales ~$6,840 ~$6,865 ~$1,685 Operating EBITDA (2) ~$1,600 ~$1,575 ~$385 Adjusted EPS (2) ~$1.66 N/A ~$0.43 *Guidance reflects the previously announced divestiture of the Aramids business and separation of the electronics business, Qnity, as discontinued operations. **Net sales updated to reflect a lower than expected currency tailwind compared to our prior guidance. “I am pleased with the strong execution in third quarter and the momentum we are building as new DuPont. As a result of our third quarter performance as well as operational improvements within the business, we are raising our full year 2025 earnings guidance,” said Antonella Franzen, DuPont Chief Financial Officer. “Organic sales growth for the full year remains in line with the guidance we provided at Investor Day, up 2 percent year-over-year on strong demand in healthcare and water end-markets partially offset by continued weakness in construction markets.” Conference Call The Company will host a live webcast of its quarterly earnings conference call with investors to discuss its results and business outlook beginning today at 8:00 a.m. ET. The slide presentation that accompanies the conference call will be posted on the DuPont’s